Ciencia e Ingeniería en Alimentos y Biotecnología
URI permanente para esta comunidadhttp://repositorio.uta.edu.ec/handle/123456789/412
Examinar
7 resultados
Resultados de la búsqueda
Item type:Ítem, Propuesta de una quimioteca de compuestos relacionados estructuralmente y diseñados para el tratamiento la enfermedad de Huntington(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Biotecnología, 2024-08) ;Sanchez Guayta, Kevin JoelGalarza Galarza, Cristian FernandoHuntington's disease (HD) is an inherited neurodegenerative disorder that affects movement, cognition and behaviour. It is characterised by uncontrollable chorea movements, difficulty speaking and swallowing, memory and thinking problems, and mood swings. HD progresses over time and usually results in death 15-20 years after diagnosis; treatment focuses on controlling symptoms. Medications can help relieve chorea movements, muscle stiffness and psychiatric problems. Physiotherapy and speech therapy may also be helpful. Research into HD is ongoing, with the goal of finding new therapies and, ultimately, a cure. Scientists are using various methods, such as bioinformatics and computer science, to identify genes and proteins that may be involved in the disease. In this study, these methods were used to identify 20 elite genes potentially implicated in HD. The researchers also identified several promising therapeutic targets, including DRD2, PDE10A and CNR1. These findings provide new insights into the molecular basis of HD and may lead to the development of new treatments. HD research is encouraging and there is steady progress towards understanding and treating this devastating disease. Scientists are working hard to find a cure, and with continued support, it is hoped that one day this goal will be achieved.Item type:Ítem, Predicción de proteínas de novo mediante inteligencia artificial para la inhibición del factor NF-κB en el cáncer gástrico(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Biotecnología, 2024-08) ;Laverde Lomas, Diego MartinGalarza Galarza, Cristian FernandoIn this research, highlights the limited effectiveness of current treatments for gastric cancer and the role of AI tools in the development of new personalized strategies, through the prediction of de novo proteins aimed at inhibiting the Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) associated with this type of cancer. Thirty proteins were predicted, with a similar composition to those stored in standard and experimental databases. Their stability and folding capacity were analyzed based on the energies from intra and intermolecular interactions by molecular dynamics simulations. Furthermore, a molecular docking process was performed between several genes or transcription factors regulated by NF-κB and the predicted proteins, different thermodynamic variables such as Gibbs Free Energy, Dissociation Constant, Enthalpy, Heat Capacity, and Entropy were calculated and compared with respect to the complex of Inhibitor Alpha of kappa B and the protein composed of the p65 and p50 subunits of NF-κB to verify the affinity of their protein-protein interaction and structural conformation state. Finally, the affinity and selectivity of the resulting interactions were evaluated, concluding that the de novo proteins predicted by artificial intelligence are viable for the generation of new treatments and the design of new drugs to treat gastric cancer.Item type:Ítem, Evaluación de posibles dianas terapéuticas para el cáncer de colon aplicando Pipeline Bioinformático como base para el diseño de fármacos asistido por computador(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Biotecnología, 2023-09) ;Jácome Campos, Mario FabricioGalarza Galarza, Cristian FernandoColon cancer is a common type of malignant tumor in the gastrointestinal tract, accounting for about 13 percent of all tumors. Its development is influenced by epigenetic changes, genetic and environmental factors. However, current methods for diagnosing and treating this disease are often expensive, making access to treatment difficult for many patients. To identify the genes that are expressed or inhibited in colon cancer, differential expression analysis was performed using R. These genes were contrasted with databases such as: OMIM, Malacards, Harmonizome, and KEGG. The most relevant genes are grouped according to their biochemical alteration, with this information biological interaction networks are created through Cytoscape to identify proteins that are altered within the disease process. For the identification of the targets, the DrugBank database was used, through DoGSiteScorer the drugable sites were identified, virtual screening is performed through MTiopenScreen to find possible ligands that present high binding affinity. The interaction networks obtained from STITCH allow the identification of the drug that is linked to the metabolic pathways to analyze the protein-ligand interactions. The drug etoposide was identified, and its pharmacokinetic and toxicity properties are assessed by bioinformatics predictions using QSAR VEGA and pkCSM models. The toxicity and hepatotoxicity were found to be negative, suggesting that this could be a viable candidate for the development of drugs targeting the SMAD2 and CASP9 genes.Item type:Ítem, Identificación de posibles dianas terapéuticas en Alzheimer utilizando pipeline bioinformático combinado para aplicarlas al diseño de fármacos asistidos por computadora(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Biotecnología, 2023-09) ;Barriga Sanchez, Luis LeonardoGalarza Galarza, Cristian FernandoBioinformatics has a potential biotechnological use because it allows the study of genetically complex diseases using different tools. The aim of this project was to analyze transcriptomic data related to Alzheimer's disease (AD) for the identification of potential therapeutic targets and computer-aided drug design. This was done through the application of a multilevel analysis of biological interaction networks, molecular docking, and evaluation of the pharmacokinetic properties of selected drugs. The analyses indicated a total of 507 and 478 genes with high and low expression, respectively, present in brains with different stages of AD. The results of the protein-protein interaction and miRNA-miRNA network analysis identified only one biomarker, hsa-mir-34a-5p, for the diagnosis of AD and asymptomatic AD in cancer patients. Survival analysis revealed that CDK6 and CD44 are potential therapeutic targets for AD. Additionally, the established pipeline also identified CCND1 as another potential therapeutic target. The drug-gene interaction networks reflected four potential drug candidates for repurposing in the treatment of AD: Estradiol, Trichostatin A, Doxorubicin, and Dorsomorphin. Molecular docking demonstrated that Estradiol and Trichostatin A can inhibit the CCND1 protein, while Dorsomorphin induces inhibition of CDK6, because of their free energy of binding is lower than the reference. The evaluation of pharmacokinetic properties indicated that only Trichostatin A can be used for the treatment of AD in humans.Item type:Ítem, Estudios bioinformáticos para la identificación de posibles dianas terapéuticas en la enfermedad de la Diabetes Mellitus tipo 2 (T2DM)(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2022-03) ;Guevara Proaño, Luis DavidGalarza Galarza, Cristian FernandoThe search for therapeutic targets for the disease type 2 diabetes mellitus is based on computer-aided drug development through molecular concentration analysis and virtual screening in disease databases. The identification of the study gene requires analysis in different databases such as MalaCards, OMIM, Harmonizome and KEGG to validate the information on the genes involved in the disease. Thus, the genes with the greatest connections are chosen and grouped according to their genetic dysfunction to create biological networks and validated in the DrugBank database. Subsequently, an analysis of the metabolic pathway taken from KEGG that connect the target genes that maintain the identified mutation is performed and the three-dimensional structures are used to evaluate the domains plus drugs. Molecular coupling and screening simulations are then carried out, considering the compounds with the highest affinity for IRS-1, and finally the toxicity of the drugs is analyzed. QSAR models show that Zosuquidar, Rimacalib, Uk432097, Mosapramine, Devazepide and Setipiprant are the safest ligand compounds in toxicity analyses. The present study is based on the identification of the genes most associated with T2DM and the search for possible therapeutic targets through bioinformatics applied to computer-assisted drug design. The results obtained can be used for subsequent research studies to increase the therapeutic spectrum for T2DM or other metabolic degenerations.Item type:Ítem, Estudios bioinformáticos para la identificación de posibles dianas terapéuticas en la enfermedad de Esclerosis Lateral Amiotrófica (ELA)(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2021-09) ;López Pérez, Iván GabrielGalarza Galarza, Cristian FernandoThe identification of new therapeutic targets for ALS disease is based on computer-aided drug design (CADD) by analyzing genes such as VCP and VABP against the Drugs-lib database, allowing the best site of action of proteins to be analyzed by virtual screening for drugability. Databases such as MalaCards, OMIM, Harmonizome and KEGG are analyzed to visualize the relevant disease genes. Elite genes that correlate with each other are chosen and grouped according to their dysfunction. In addition, biological networks are created and validated with the DrugBank database. Next, the metabolic pathway of the genes that follow the SOD1 gene mutations is analyzed and the most druggable domains are identified. Finally, the toxicological properties of the linked drugs are analyzed. The search for drug-interacting therapeutic targets is the aim of the present study. The results obtained through virtual screening allow the identification of drugs that may have effects on the disease, these are: Saquinavir and Astemizole, which are associated with the VCP and VABP genes, respectively. The drug Astemizole has better QSAR properties. The importance of the present study is the identification of the most relevant genes and the search for therapeutic targets in Amyotrophic Lateral Sclerosis. The information obtained could be used as a starting point for research into new drugs to counteract neurodegeneration.Item type:Ítem, Estudios informáticos de la enzima de Trypanosoma brucei hipoxantina-guanina-xantina fosforribosiltransferasa para el uso como target de desarrollo de medicamentos(Universidad Técnica de Ambato. Facultad de Ciencia e Ingeniería en Alimentos y Biotecnología. Carrera de Ingeniería Bioquímica, 2019-12) ;Hernández Orozco, Jhonny StalynMera Terán, David AndrésThe computer-studies conducted on the enzyme hypoxanthine-guanine-xanthine phosphoribosyltransferase from T. brucei (TbHGXPRT) as a target for drug development were docking, refinement of structures and a phylogenetic analysis. The docking process consisted of using a library of compounds (CASPeR), the purpose of the study was to determine those compounds (drugs) that are potential inhibitors of the TbHGXPRT enzyme. The result of the study determined that 381 drugs have a significant Ki and therefore can be considered as potential inhibitors. The refinement process was carried out with two specific ligands (ANPs), this refinement process provides information about the interactions that are generated between the residues of the active site and the ligand. This information was used to observe how the 20 drugs selected in the docking study are located in the active site of the TbHGXPRT enzyme. The last analysis was the phylogenetic study of the phosphoribosyltransferase (PRTases) enzyme family, in this study the alignment of the protein sequences of 30 enzymes belonging to the PRTases family of several organisms was performed. Based on the alignment, it was possible to determine those organisms that presented highly conserved waste sites and those that had variations in these sites. The study is important because the compounds selected from the docking study can be used for in vitro and in vivo tests against the parasite. In addition, the phylogenetic study will allow these compounds to be tested in other parasites that have enzymes from the PRTase family.
